The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Experimental research
First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system
EuroInterv.2007;3:142-148.
Emerson C. Perin1*, MD, PhD; Guilherme V. Silva1, MD; Marlos R. Fernandes1, MD; Torrey Munger2, PhD; Ashwini Pandey2, MSc; Ruchir Sehra2, MD; Michael Talcott3, DVM; Christopher J. Bichard4; Jerett Creed4, BSIE, MSAcc; Jonathan W.C. Wong4, MS; Edie M. Oliveira1, MD; Yi Zheng1, MD; John Canales1, MD; Cristiano O. Cardoso1, MD; Mark S. Patterson5,6, MSc, MRCP; Patrick W. Serruys5, MD, PhD, FACC, FESC
1. Texas Heart Institute at St. Luke’s Episcopal Hospital, Houston, TX, USA; 2. Stereotaxis, Inc., St. Louis, MO, USA; 3. Washington University School of Medicine, St. Louis, MO, USA; 4. Cordis Corp., Diamond Bar, CA, USA; 5. Thoraxcenter, Erasmus Medical
Aims: The purpose of this preclinical feasibility study was to evaluate a novel integrated platform in which magnetic navigation is used to remotely guide electromechanical mapping of the left ventricle (LV) and